CIK 0001388320
- Non-accelerated filer
- Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880378336
- Phone
- +1 646-677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 4 Open-market buy Principal Financial Officer bought 10,000 shares at $0.44 ($4,350)
- 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.45 ($4,499)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 10,000 shares at $0.79 ($7,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Principal Financial Officer bought 12,000 shares at $0.50 ($6,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chairman & CEO bought 5,000 shares at $0.38 ($1,900)
- 4 Other acquisition Chief Medical Officer acquired 14,000 shares (other)
- 4 Other acquisition Chairman & CEO acquired 52,500 shares (other)
- 4 Other acquisition Executive VP acquired 10,000 shares (other)
- 4 Other acquisition Director acquired 7,000 shares (other)
- 4 Other acquisition Principal Financial Officer acquired 10,000 shares (other)
- 4 Open-market buy Director bought 22,730 shares at $0.43 ($9,774)
- 3 Insider Initial Statement of Ownership
Page 4 of 8 · 146 filings